An increase in miR155 levels maintained chronic skin inflammation through the modulation of CD4+ T cells and dendritic cells and the action on cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), which is a negative regulator of T lymphocyte activity [54]. Here, CTLA4 is linked to dermatitis.